Donor leukocyte infusion for treatment of graft rejection post partially mismatched related donor bone marrow transplant

Bone Marrow Transplantation

Volumn 22, Issue 1, 1998, Pages 111-113

  Godder, K T ^a,b,d   Abhyankar, S H ^a,b   Lamb, L S ^a   Best, R G ^c   Geier, S S ^a   Pati, A R ^a,b   Gee, A P ^a   Henslee Downey, P J ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Palmetto Richland Memorial Hospital   (United States)

^c Division of Clinical Genetics   (United States)

^d Department of Obstetrics ^*  (United States)

Author keywords

Bone marrow transplantation; CML; Donor leukocyte infusion; Graft rejection; Partially mismatched related donor

Indexed keywords

CHLORMETHINE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; GRAFT REJECTION; HEMATOPOIESIS; HOST CELL; HUMAN; LEUKOCYTE TRANSFUSION; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0031848141     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701278     Document Type: Article

References (16)

1. Anasetti, C, Amos, D, Beatty PG. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197-204.
2. Kernan NA. Graft failure following transplantation of T cell depleted marrow. In: Burakoff SD (ed). Graft versus Host Disease: Research and Clinical Management. Marcel Dekker: New York, 1990, p 557.
3. Lamb LS, Gee AP, Parrish RS et al. Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristics. Bone Marrow Transplant 1996; 17: 1021-1027.
4. Donohue J, Homage M, Kernan N. Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 1993; 82: 1023-1029.
5. Henslee-Downey PJ, Abhyankar SH, Parish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-3872.
6. Lamb LS, Szafer F, Henslee-Downey PJ et al. Characterization of acute bone marrow graft rejection in T-cell depleted, partially mismatched related donor bone marrow transplantation. Exp Hematol 1995; 23: 1595-1600.
7. Martin PJ. Influence of alloreactive T cells on initial hematopoietic reconstitution after marrow transplant. Exp Hematol, 1995; 23: 174-179.
8. Slavin S, Or R, Naparstek E et al. Cellular mediated immunotherapy of leukemia in conjuction with autologous and allogeneic bone marrow transplantation in experimental animals and man. Blood 1988; 72: (Suppl. 1) (Abstr. 407).
9. Kolb HJ, Mittermuller J, Clemm CH et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
10. Papadopoulos EB, Ladannyi M, Emanuel D et al. Infusion of donor leukocytes to treat virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
11. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allograft. Blood 1995; 85: 1659-1665.
12. Ferster A, Bujan W, Mouraux T et al. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant 1994; 14: 331-332.
13. Pati AR, Godder K, Lamb L et al. Immunotherapy with donor leukocyte infusions for patients with relapsed acute myeloid leukemia following partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 1995; 15: 979-981.
14. Stachel D, Schmid I, Straka C et al. Allogeneic peripheral blood stem cell (PBSC) transplantation in two patients with graft failure. Bone Marrow Transplant 1995; 16: 839-842.
15. Zecca M, Perotti C, Marradi P et al. Recombinant human G-CSF mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children. Br J Haematol 1996; 9: 432-434.
16. Pati AR, Godder K, Abhyankar S et al. Pre-emptive donor leukocyte infusion (DLI) to prevent relapse in patients (PTS) with high risk hematological malignancies undergoing bone marrow transplant (BMT) using partially mismatched related donors (PMRD). Blood 1995; 86: (Suppl. 1) (Abstr. 564).